Mark J. Gergen, SVP, Corporate Development at AMYLIN PHARMACEUTICALS INC (AMLN), sold 7,518 shares at $17.03 ($128K) on 2012-02-23, disclosed to the SEC on 2012-02-24.
Seasonal sale ($128k) by SVP, Corporate Development — this insider has traded AMLN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| MRTX | SELL | 2016-01-19 | $518K | — | Filing → |
| AMLN | SELL | 2012-03-02 | $32K | — | Filing → |
| AMLN | SELL | 2007-11-02 | $22K | — | Filing → |